EU MDR approval is expected by about September this year. TGA considers that data in the application for regulatory approval in Australia and if this is data is accepted, turn around time for TGA approval can be in as little as a month or two. TGA takes EU MDR approval seriously.
FDA approval which is also aim of Oncosil is also going to play a major role in opening different markets and expansion possibilities around the world. Market Cap as well as stock price should reflect this.
Ann: Australian institution to invest $2.7 million in OSL, page-38
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.025(2.43%) |
Mkt cap ! $14.29M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.05 | $1.00 | $41.05K | 40.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 1249 | 1 |
View Market Depth
| Last trade - 15.47pm 20/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |